Ardent Health (ARDT) director Edmondo Robinson awarded 14,231 restricted stock units

Rhea-AI Filing Summary

Robinson Edmondo reported acquisition or exercise transactions in this Form 4 filing.

Ardent Health, Inc. director Edmondo Robinson received a grant of 14,231 shares of Common Stock in the form of restricted stock units. These units vest in full on the first anniversary of April 1, 2026, if he remains in service with the company through that date. Following this award, he directly holds 58,215 shares of Common Stock.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Robinson Edmondo

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	14,231	$0.00	--

Holdings After Transaction: Common Stock — 58,215 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

RSU grant size: 14,231 shares Grant price: $0.00 per share Post-transaction holdings: 58,215 shares +1 more

4 metrics

RSU grant size 14,231 shares Restricted stock units granted to director on April 1, 2026

Grant price $0.00 per share Compensation-related award, not open-market purchase

Post-transaction holdings 58,215 shares Total common stock held directly after the grant

Vesting timing First anniversary of April 1, 2026 RSUs vest in full on this date if service continues

Key Terms

restricted stock units, vest in full, continued service, grant, award, or other acquisition

4 terms

restricted stock units financial

"Represents restricted stock units that vest in full on the first anniversary"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

vest in full financial

"restricted stock units that vest in full on the first anniversary"

continued service financial

"subject to the Reporting Person's continued service with the Issuer"

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Robinson Edmondo

(Last) (First) (Middle)

340 SEVEN SPRINGS WAY, SUITE 100

(Street)

BRENTWOOD TENNESSEE 37027

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Ardent Health, Inc. [ ARDT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/01/2026		A		14,231(1)	A	$0	58,215	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units that vest in full on the first anniversary of April 1, 2026, subject to the Reporting Person's continued service with the Issuer through the vesting date.

Remarks:

	/s/ Stephen C. Petrovich, Attorney-in-Fact	04/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did ARDT director Edmondo Robinson report?

Edmondo Robinson reported receiving a grant of 14,231 restricted stock units of Ardent Health, Inc. common stock. This is a compensation-related award, not an open-market purchase or sale, and was received at a price of $0.00 per share.

When do Edmondo Robinson’s new ARDT restricted stock units vest?

The 14,231 restricted stock units vest in full on the first anniversary of April 1, 2026. Vesting is contingent on Robinson’s continued service with Ardent Health, Inc. through that vesting date, according to the filing footnote.

How many Ardent Health (ARDT) shares does Edmondo Robinson hold after this grant?

After the reported grant, Edmondo Robinson directly holds 58,215 shares of Ardent Health, Inc. common stock. This total includes the newly awarded restricted stock units, which remain subject to future vesting conditions based on continued service.

Was Edmondo Robinson’s ARDT transaction a market buy or sell?

No, the transaction was not a market buy or sell. It is classified as a grant or award acquisition of 14,231 restricted stock units, received at $0.00 per share as part of compensation, rather than an open-market trade in Ardent Health, Inc. stock.

What conditions are attached to the ARDT restricted stock units granted to Robinson?

The restricted stock units will vest only if Edmondo Robinson continues to serve with Ardent Health, Inc. through the vesting date. The filing states they vest in full on the first anniversary of April 1, 2026, subject to this continued service requirement.